Skip to main content
SpringerLink
Log in

Management of Infective Complications Following Prostate Biopsy

  • Chapter
  • First Online:
Prostatitis and Its Management

  • 709 Accesses

Abstract

An estimated one million sets of prostate biopsies are taken annually both in the USA and in the EU [1]. Approximately 30 % of patients have undergone at least one previous set of prostate biopsies [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM (2011) Complications after prostate biopsy: data from SEER-Medicare. J Urol 186:1830–1834

    Article  PubMed  Google Scholar 

  2. Wagenlehner FM et al (2013) Infective complications after prostate biopsy: outcome of the global prevalence study of infections in urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol 63:521–527

    Article  PubMed  Google Scholar 

  3. Crawford ED, Haynes AL Jr, Story MW, Borden TA (1982) Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. J Urol 127(3):449–451

    CAS  PubMed  Google Scholar 

  4. Ehdaie B, Vertosick E, Spaliviero M et al (2014) The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance. J Urol 191:660–664

    Article  PubMed  Google Scholar 

  5. Birkebæk FT, Berg KD, Iversen P, Brasso K (2015) Poor association between the progression criteria in active surveillance and subsequent histopathological findings following radical prostatectomy. Scandinavian J Urol 49:1–6. doi:10.3109/21681805.2015.1040448

    Google Scholar 

  6. European Association of Urology. Individual guidelines.www.uroweb.org/guidelines (4.3.2015)

  7. Dellinger RP et al (2012) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 41:580–637

    Article  Google Scholar 

  8. Rangel-Frausto MS, Pittet D, Costigan M et al (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273(2):117–123

    Article  CAS  PubMed  Google Scholar 

  9. Nam RK et al (2010) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 183:963–968

    Article  PubMed  Google Scholar 

  10. Carmignani L et al (2012) Bacterial sepsis following prostatic biopsy. Int Urol Nephrol 44:1055–1063

    Article  PubMed  Google Scholar 

  11. Batura D, Gopal Rao G (2013) The national burden of infections after prostate biopsy in England and Wales: a wake-up call for better prevention. J Antimicrob Chemother 68:247–249

    Article  CAS  PubMed  Google Scholar 

  12. Wagenlehner F, Stower-Hoffmann J, Schneider-Brachert W, Naber KG, Lehn N (2000) Influence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology. Int J Antimicrob Agents 15:207–211

    Article  CAS  PubMed  Google Scholar 

  13. Carratala J, Fernandez-Sevilla A, Tubau F, Dominguez MA, Gudiol F (1996) Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis. Antimicrob Agents Chemother 40(2):503–505

    PubMed Central  CAS  PubMed  Google Scholar 

  14. DiBianco JM, Allaway M (2014) Freehand ultrasound-guided transperineal prostate biopsy: technique and early results. J Endourol. doi:10.1089/vid.2014.0046

    Google Scholar 

  15. Pepe P, Aragona F (2013) Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores. Urology 81:1142–1146

    Article  PubMed  Google Scholar 

  16. Haas GP, Delongchamps N, Brawley OW et al (2008) The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol 15(1):3866–3871

    PubMed Central  PubMed  Google Scholar 

  17. Hoogendam A, Buntinx F, devet HC (1999) The diagnostic value of digital rectal examination in primary care screening for prostate cancer: a meta-analysis. Fam Pract 16:621

    Article  CAS  PubMed  Google Scholar 

  18. Coley CM, Barry MJ, Fleming C, Mulley AG (1997) Early detection of prostate cancer. Part I: prior probability and effectiveness of tests. The American College of Physicians. Ann Intern Med 126:394

    Article  CAS  PubMed  Google Scholar 

  19. Mouraviev V, Lee B, Patel V, Albala D, Johansen TEB, Partin A, Ross A, Perera RJ (2015) Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer. Prostate Cancer Prostatic Dis. doi:10.1038/pcan.2015.48. [Epub ahead of print]

    Google Scholar 

  20. Steensels D et al (2012) Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy – should we reassess our practices for antibiotic prophylaxis? Clin Microbiol Infect 18:575–581

    Article  CAS  PubMed  Google Scholar 

  21. Bjerklund Johansen TE, Botto H, Cek M et al (2011) Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system. IJAA 38(Suppl):64–70

    Google Scholar 

  22. Bedalov G, Vuckovic I, Fridrich S et al (1994) Prostatitis in benign prostatic hyperplasia: a histological, bacteriological and clinical study. Acta Med Croatica 48:105–109

    CAS  PubMed  Google Scholar 

  23. Howard JM, Barker WF, Culbertson WR et al (1964) Postoperative wound infections: the influence of ultraviolet irradiation of the operating room and of various other factors. Ann Surg 160(Suppl):1–192

    Google Scholar 

  24. Culver DH, Horan TC, Gaynes RP et al (1991) Surgical wound infection rates by wound class, operative procedure, and patient risk index. Am J Med 91(Suppl 3B):152S–1157S

    Article  CAS  PubMed  Google Scholar 

  25. Grabe M, Botto H, Cek M, Tenke P, Wagenlehner FME, Naber KG, Bjerklund Johansen TE (2012) Preoperative assessment of the patient and risk factors for infectious complications and tentative classification of surgical field contamination of urological procedures. World J Urol 30:39–50

    Article  PubMed  Google Scholar 

  26. Jeon SS, Woo SH, Hyun JH, Choi HY, Chai SE (2003) Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy. Urology 62:461–466

    Article  PubMed  Google Scholar 

  27. Abughosh Z, Margolick J, Goldenberg SL (2013) A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. J Urol 189(4):1326–1331. doi:10.1016/j.juro.2012.09.121, Epub 2012 Oct 2

    Article  CAS  PubMed  Google Scholar 

  28. Cek M, Tandogdu Z, Naber K, Tenke P, Kristiansen B, Bjerklund Johansen TE (2013) Antimicrobial prophylaxis in urology departments 2005–2010. Eur Urol 63:386–394

    Article  PubMed  Google Scholar 

  29. Wagenlehner FM, Weidner W, Sorgel F, Naber KG (2005) The role of antibiotics in chronic bacterial prostatitis. Int J Antimicrob Agents 26:1–7

    Article  CAS  PubMed  Google Scholar 

  30. Naber KG, Sorgel F (2003) Antibiotic therapy – rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue. Andrologia 35:331–335

    Article  CAS  PubMed  Google Scholar 

  31. Goto T et al (1998) Diffusion of piperacillin, cefotiam, minocycline, amikacin and ofloxacin into the prostate. Int J Urol 5:243–246

    Article  CAS  PubMed  Google Scholar 

  32. Naber KG et al (1991) Concentrations of cefpodoxime in plasma, ejaculate and in prostatic fluid and adenoma tissue. Infection 19:30–35

    Article  CAS  PubMed  Google Scholar 

  33. Nishikawa G et al (2013) Prostatic penetration of meropenem in humans, and dosage considerations for prostatitis based on a site-specific pharmacokinetic/pharmacodynamic evaluation. Int J Antimicrob Agents 41:267–271

    Article  CAS  PubMed  Google Scholar 

  34. Nakamura K et al (2012) Determination of doripenem penetration into human prostate tissue and assessment of dosing regimens for prostatitis based on site-specific pharmacokinetic-pharmacodynamic evaluation. J Chemother 24:32–37

    Article  CAS  PubMed  Google Scholar 

  35. Wright WL, Larking P, Lovell-Smith CJ (1982) Concentrations of trimethoprim and sulphamethoxazole in the human prostate gland after intramuscular injection. Br J Urol 54:550–551

    Article  CAS  PubMed  Google Scholar 

  36. Jernberg C, Löfmark S, Edlund C, Jansson JK (2010) Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 156(Pt 11):3216–3223. doi:10.1099/mic.0.040618-0, Epub 2010 Aug 12

    Article  CAS  PubMed  Google Scholar 

  37. Wagenlehner FME, Pilatz A, Waliszewski P, Weidner W, Bjerklund-Johansen TE (2014) Reducing infection rates during prostate biopsy. Nat Rev Urol 11:80–86. doi:10.1038/nrurol.2013.322

    Article  PubMed  Google Scholar 

  38. Kahlmeter G (2003) Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. IJAA 22(Suppl 2):49–52

    Google Scholar 

  39. Schaeffer AJ, Weidner W, Barbalias GA et al (2003) Summary, consensus statement: diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome. Eur Urol 43(2):1–4

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Oslo University Hospital, Oslo, Norway

    Truls E. Bjerklund Johansen & Catherine E. P. Pereira

  2. Institute of Clinical Medicine, University of Aarhus, Aarhus, Denmark

    Truls E. Bjerklund Johansen

  3. Global Robotics Institute, Florida Hospital Celebration Health, Celebration, Kissimmee, FL, USA

    Vladimir Mouraviev

Authors
  1. Truls E. Bjerklund Johansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Catherine E. P. Pereira
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vladimir Mouraviev
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Truls E. Bjerklund Johansen .

Editor information

Editors and Affiliations

  1. Dept. of Urology, Santa Chiara Regional Hospital, Trento, Italy

    Tommaso Cai

  2. Department of Urology, Oslo University Hospital, Oslo, Norway

    Truls E. Bjerklund Johansen

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Bjerklund Johansen, T.E., Pereira, C.E.P., Mouraviev, V. (2016). Management of Infective Complications Following Prostate Biopsy. In: Cai, T., Bjerklund Johansen, T. (eds) Prostatitis and Its Management. Springer, Cham. https://doi.org/10.1007/978-3-319-25175-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-25175-2_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-25173-8

  • Online ISBN: 978-3-319-25175-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation